Stipan Jonjic
Sveucilište u Rijeci
H-index: 71
Europe-Croatia
Top articles of Stipan Jonjic
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
First-in-class anti-PVR mAb NTX1088 advancing through Phase I: Safe and potent in restoring DNAM1 expression to enhance antitumor immunity | Cancer Research | Anas Atieh Akram Obeidat Alon Vitenshtein Guy Cinamon Keren Paz | 2024/3/22 |
Innate lymphoid cells in neuroinflammation | Daria Kveštak Andrea Mihalić Stipan Jonjić Ilija Brizić | 2024/2/21 | |
Antibodies specific to human poliovirus receptor (pvr) | 2024/1/18 | ||
Maternal antibodies induced by a live attenuated vaccine protect neonatal mice from cytomegalovirus | npj Vaccines | Vu Thuy Khanh Le-Trilling Andreja Jagnjić Ilija Brizić Mareike Eilbrecht Kerstin Wohlgemuth | 2023/2/3 |
Reovirus infection of tumor cells reduces the expression of NKG2D ligands, leading to impaired NK-cell cytotoxicity and functionality | Frontiers in Immunology | Raghad Khaleafi Jelena Zeleznjak Sapir Cordela Shani Drucker Tihana Lenac Rovis | 2023/9/11 |
TIGIT can inhibit T cell activation via ligation-induced nanoclusters, independent of CD226 co-stimulation | Nature Communications | 2023/8/18 | |
Antibodies to nkp46 and constructs thereof for treatment of cancers and infections | 2023/6/15 | ||
Correction to: Activation of CEACAM1 with an agonistic monoclonal antibody results in inhibition of melanoma cells | Cancer Gene Therapy | Ilan Zaffran Nadine Landolina Pratibha Gaur Tihana Lenac Rovis Stipan Jonjic | 2023/6 |
Combined Treatment with Host-Directed and Anticytomegaloviral Kinase Inhibitors: Mechanisms, Synergisms and Drug Resistance Barriers | Pharmaceutics | Markus Wild Dubravka Karner Jan Eickhoff Sabrina Wagner Jintawee Kicuntod | 2023/11/27 |
Decoding murine cytomegalovirus | Plos Pathogens | Manivel Lodha Ihsan Muchsin Christopher Jürges Vanda Juranic Lisnic Anne L’hernault | 2023/5/12 |
Perinatal murine cytomegalovirus infection reshapes the transcriptional profile and functionality of NK cells | Nature communications | Carmen Rožmanić Berislav Lisnić Marina Pribanić Matešić Andrea Mihalić Lea Hiršl | 2023/10/12 |
First-in-class anti-PVR mAb NTX1088 restores DNAM1 expression and enhances antitumor immunity | European Journal of Cancer | A Atieh A Obiedat A Vitenshtein G Cinamon K Paz | 2022/10/1 |
Characterization of M116. 1p, a murine cytomegalovirus protein required for efficient infection of mononuclear phagocytes | Journal of virology | Tina Ružić Vanda Juranić Lisnić Hana Mahmutefendić Lučin Tihana Lenac Roviš Jelena Železnjak | 2022/1/26 |
SARS-CoV-2 viral load in the pulmonary compartment of critically ill COVID-19 patients correlates with viral serum load and fatal outcomes | Viruses | Mario Ynga-Durand Henrike Maaß Marko Milošević Fran Krstanović Marina Pribanić Matešić | 2022/6/14 |
Anti-human ACE2 antibody neutralizes and inhibits virus production of SARS-CoV-2 variants of concern | Iscience | Abigael E Chaouat Ilija Brizic Paola Kucan Brlic Nofar Atari Limor Kliker | 2022/9/16 |
Two murine cytomegalovirus microRNAs target the major viral immediate early 3 gene | Journal of General Virology | Stefanie Herb Jelena Zeleznjak Thomas Hennig Anne L'Hernault Manivel Lodha | 2022/11/21 |
Abstract P075: NTX-1088, a potent first-in-class, anti-PVR mAb, restores expression and function of DNAM1 for optimal DNAM1-mediated antitumor immunity | Cancer Immunology Research | Pini Tsukerman Anas Atieh Akram Obeidat Keren Paz Guy Cinamon | 2022/1/1 |
ChAdOx1‐S adenoviral vector vaccine applied intranasally elicits superior mucosal immunity compared to the intramuscular route of vaccination | European journal of immunology | Maja Cokarić Brdovčak Jelena Materljan Marko Šustić Sanda Ravlić Tina Ružić | 2022/6 |
SARS-CoV-2 spike and nucleocapsid antibody response in vaccinated croatian healthcare workers and infected hospitalized patients: a single center cohort study | Viruses | Paola Kučan Brlić Martina Pavletić Mate Lerga Fran Krstanović Marina Pribanić Matešić | 2022/9/4 |
474 First-in-class anti-PVR mAb NTX1088 restores expression of DNAM1 and augments antitumor immunity | Akram Obeidat Anas Atieh Alon Vitenshtein Guy Cinamon Keren Paz | 2022/11/1 |
